PRODUCT RELEASE
SAN DIEGO, CA – August 2019
NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking
PRODUCT RELEASE
SAN DIEGO, CA – August 2019
NOW AVAILABLE! MRD solutions for B- and T-cell clonality tracking
MRD Clonality
Minimal Residual Disease (MRD) is the presence of low levels of malignant cells that remain in a subject during or after treatment or when the patient is in remission. Detectable levels of cancer cells following treatment may suggest a higher probability of relapse.
SHARE THIS PRODUCT RELEASE
MRD Clonality
Minimal Residual Disease (MRD) is the presence of low levels of malignant cells that remain in a subject during or after treatment or when the patient is in remission. Detectable levels of cancer cells following treatment may suggest a higher probability of relapse.
